Model Medicines files Form D for $8 million offering
The San Diego-based company has sold $5.1 million of the equity offering to 37 investors so far, according to an SEC filing.
Model Medicines, Inc. filed a Form D with the Securities and Exchange Commission disclosing an exempt securities offering. The filing lists the date of first sale as 2026-10-15.1
The company's principal place of business is listed at 5120 Shoreham Place, Suite 285, San Diego, California 92122.1 Daniel Haders is named as a related person, identified as an executive officer and president.1
For industry classification, the filing checked "Other" among the Industry Group options, which also included categories such as Biotechnology, Pharmaceuticals, and Health Care, rather than selecting a health care related category.1
On the offering terms, the securities being offered are equity.1 The total offering amount is listed as $8,000,000, with $5,115,268 already sold and $2,884,732 remaining to be sold.1 The filing states that 37 investors have already invested in the offering.1
The minimum investment accepted from any outside investor is listed as $0.1 The filing reports $0 in sales commissions and $0 in finders' fees.1 The amount designated for payments to executive officers, directors, or promoters from the offering proceeds is also listed as $0.1
The company claims an exemption under Rule 506(b) of Regulation D.1 The filing indicates the offering is not being made in connection with a business combination transaction such as a merger or acquisition.1 The notice was signed by Daniel Haders, as president, on 2026-10-21.1
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.